Skip to content
lifestyle.duovoltart.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Decoy Therapeutics, Inc
Decoy Therapeutics’ CEO to Participate in hVIVO Capital Markets Day in London
June 8, 2026
Decoy Therapeutics Nominates Global Biopharma Executive Patricia Gauthier for Election to Board of Directors
June 3, 2026
Decoy Therapeutics Partners with hVIVO to Advance Lead D-MAV™ Candidate into the Clinic
June 1, 2026
Decoy Therapeutics Names Brad Pentelute, MIT Professor of Chemistry, as Chair of Scientific Advisory Board
May 26, 2026
Decoy Therapeutics to Present at Two Peptide Therapeutics Conferences in Boston
April 27, 2026
Decoy Therapeutics Builds Momentum with Accelerating Execution, Entering a Highly Catalytic Phase with a Clearly Defined Path to Clinical Development of its Antiviral Pipeline
April 9, 2026
Decoy Therapeutics to Participate in Virtual Investor Closing Bell Event Highlighting Business Outlook for 2026
April 6, 2026
Decoy Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
April 2, 2026
Decoy Therapeutics Enters Strategic Partnership with Quantori to Deploy Google Cloud-native Integrated AI-Driven Peptide Design and Molecular Simulation Platform
March 11, 2026
Decoy Therapeutics Announces 1-for-12 Reverse Stock Split
March 5, 2026
1
2
Next Page
→